These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 1096219)
41. Behavioral effects of prolonged administration of delta 9-tetrahydrocannabinol in the rat. Stiglick A; Kalant H Psychopharmacology (Berl); 1983; 80(4):325-30. PubMed ID: 6312481 [TBL] [Abstract][Full Text] [Related]
42. Sensory, perceptual, motor and cognitive functioning and subjective reports following oral administration of delta9-tetrahydrocannabinol. Peters BA; Lewis EG; Dustman RE; Straight RC; Beck EC Psychopharmacologia; 1976 May; 47(2):141-8. PubMed ID: 1273209 [TBL] [Abstract][Full Text] [Related]
43. The effect of 1- delta 1-trans-tetrahydrocannabinol on learning and retention of avoidance performance in rats. Herring B Psychopharmacologia; 1972; 26(4):401-6. PubMed ID: 4638204 [No Abstract] [Full Text] [Related]
44. Acute psychotropic effects of oral cannabis extract with a defined content of Delta9-tetrahydrocannabinol (THC) in healthy volunteers. Kaufmann RM; Kraft B; Frey R; Winkler D; Weiszenbichler S; Bäcker C; Kasper S; Kress HG Pharmacopsychiatry; 2010 Jan; 43(1):24-32. PubMed ID: 20178093 [TBL] [Abstract][Full Text] [Related]
45. Delta 9-tetrahydrocannabinol: aversive effects in rat at high doses. Elsmore TF; Fletcher GV Science; 1972 Feb; 175(4024):911-2. PubMed ID: 5008609 [TBL] [Abstract][Full Text] [Related]
46. Changes of simple somatic parameters by delta-9-trans-tetrahydrocannabinol (delta-9-THC) in a double-blind-study. Short communication. Zimmer BD; Bickel P; Dittrich A Arzneimittelforschung; 1976; 26(8):1614-6. PubMed ID: 795438 [TBL] [Abstract][Full Text] [Related]
47. Medicinal Δ(9) -tetrahydrocannabinol (dronabinol) impairs on-the-road driving performance of occasional and heavy cannabis users but is not detected in Standard Field Sobriety Tests. Bosker WM; Kuypers KP; Theunissen EL; Surinx A; Blankespoor RJ; Skopp G; Jeffery WK; Walls HC; van Leeuwen CJ; Ramaekers JG Addiction; 2012 Oct; 107(10):1837-44. PubMed ID: 22553980 [TBL] [Abstract][Full Text] [Related]
48. Effects of marijuana extract and tetrahydrocannabinol on electroencephalographic sleep patterns. Feinberg I; Jones R; Walker J; Cavness C; Floyd T Clin Pharmacol Ther; 1976 Jun; 19(6):782-94. PubMed ID: 178475 [TBL] [Abstract][Full Text] [Related]
49. Effects of marihuana in laboratory animals and in man. Carlini EA; Karniol IG; Renault PF; Schuster CR Br J Pharmacol; 1974 Feb; 50(2):299-309. PubMed ID: 4609532 [TBL] [Abstract][Full Text] [Related]
50. Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis. D'Souza DC; Ranganathan M; Braley G; Gueorguieva R; Zimolo Z; Cooper T; Perry E; Krystal J Neuropsychopharmacology; 2008 Sep; 33(10):2505-16. PubMed ID: 18185500 [TBL] [Abstract][Full Text] [Related]
51. Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract. Nadulski T; Pragst F; Weinberg G; Roser P; Schnelle M; Fronk EM; Stadelmann AM Ther Drug Monit; 2005 Dec; 27(6):799-810. PubMed ID: 16306858 [TBL] [Abstract][Full Text] [Related]
52. Proceedings: Pharmacokinetics in relation to physiological and psychological effects of delta-8-THC. Levander S; Binder M; Agurell S; Bader-Bartfai A; Gustafsson K; Lindgren J; Leander K; Olsson A; Tobisson B Acta Pharm Suec; 1974 Dec; 11(6):662-3. PubMed ID: 1094806 [No Abstract] [Full Text] [Related]
53. Delta-9-tetrahydrocannabinol and synhexl: effects on human sleep patterns. Pivik RT; Zarcone V; Dement WC; Hollister LE Clin Pharmacol Ther; 1972; 13(3):426-35. PubMed ID: 4337346 [No Abstract] [Full Text] [Related]
54. Delta 9-tetrahydrocannabinol produced discrimination in pigeons. Henriksson BG; Johansson JO; Järbe TU Pharmacol Biochem Behav; 1975; 3(5):771-4. PubMed ID: 1208619 [TBL] [Abstract][Full Text] [Related]
55. Cardiovascular effects of cannabinol during oral surgery. Gregg JM; Campbell RL; Levin KJ; Ghia J; Elliott RA Anesth Analg; 1976; 55(2):203-13. PubMed ID: 769605 [TBL] [Abstract][Full Text] [Related]
56. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. D'Souza DC; Perry E; MacDougall L; Ammerman Y; Cooper T; Wu YT; Braley G; Gueorguieva R; Krystal JH Neuropsychopharmacology; 2004 Aug; 29(8):1558-72. PubMed ID: 15173844 [TBL] [Abstract][Full Text] [Related]
57. Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users. Curran HV; Brignell C; Fletcher S; Middleton P; Henry J Psychopharmacology (Berl); 2002 Oct; 164(1):61-70. PubMed ID: 12373420 [TBL] [Abstract][Full Text] [Related]
58. Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans. Wachtel SR; ElSohly MA; Ross SA; Ambre J; de Wit H Psychopharmacology (Berl); 2002 Jun; 161(4):331-9. PubMed ID: 12073159 [TBL] [Abstract][Full Text] [Related]
59. The acute effects of tetrahydrocannabinol on auditory threshold and frequency resolution in human subjects. Mulheran M; Middleton P; Henry JA Hum Exp Toxicol; 2002 Jun; 21(6):289-92. PubMed ID: 12195931 [TBL] [Abstract][Full Text] [Related]